Thomas M. Maddox

Endocrinology, Diabetes and Metabolism · 2009–2016

A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 4 researchers here, as inferred from the citation graph.

Subfields

Whom Thomas M. Maddox trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Marja-Riitta Taskinen

Who trusts Thomas M. Maddox overall

  1. Kornelia M. Batko
  2. Nishita Mehta

Papers from Thomas M. Maddox's perspective

Ordered by how strongly the researchers Thomas M. Maddox trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. (Journal of the American College of Cardiology)
  2. The Seattle Heart Failure Model: Prediction of Survival in Heart Failure (Circulation)
  3. Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction (Circulation)
  4. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. (Journal of the American Medical Association (JAMA))
  5. Clopidogrel for Coronary Stenting Response Variability, Drug Resistance, and the Effect of Pretreatment Platelet Reactivity (Circulation)
  6. Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet Aggregation: A New Drug–Drug Interaction (Circulation)
  7. Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects. (Blood)
  8. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. (New England Journal of Medicine)
  9. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study (British medical journal)
  10. A central role for JNK in obesity and insulin resistance (Nature)

Their papers